Virus‐Free and Live‐Cell Visualizing SARS‐CoV‐2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors

Author:

Zhang Yali1,Wang Shaojuan1,Wu Yangtao1,Hou Wangheng1,Yuan Lunzhi1,Shen Chenguang2,Wang Juan1,Ye Jianghui1,Zheng Qingbing1,Ma Jian1,Xu Jingjing3,Wei Min1,Li Zonglin1,Nian Sheng1,Xiong Hualong1,Zhang Liang1,Shi Yang1,Fu Baorong1,Cao Jiali1,Yang Chuanlai1,Li Zhiyong4,Yang Ting3,Liu Lei2,Yu Hai1,Hu Jianda3,Ge Shengxiang1,Chen Yixin1,Zhang Tianying1,Zhang Jun1,Cheng Tong1,Yuan Quan1,Xia Ningshao1ORCID

Affiliation:

1. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics National Institute of Diagnostics and Vaccine Development in Infectious Diseases School of Public Health & School of Life Sciences Xiamen University Xiamen Fujian 361102 China

2. Shenzhen Key Laboratory of Pathogen and Immunity National Clinical Research Center for Infectious Disease Shenzhen Third People's Hospital Second Hospital Affiliated to Southern University of Science and Technology Shenzhen Guangdong 518112 China

3. Department of Hematology Fujian Medical University Union Hospital Fujian Provincial Key Laboratory on Hematology Fujian Institute of Hematology Fuzhou Fujian 350001 China

4. The First Hospital of Xiamen University Xiamen 361003 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Materials Science,General Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3